Cancer patients exhibit a high rate of thromboembolism (VTE). In this study, we analyzed levels of microparticle (MP) tissue factor (TF) activity in cancer patients with or without VTE …
Cancer patients exhibit a high rate of thromboembolism (VTE). In this study, we analyzed levels of microparticle (MP) tissue factor (TF) activity in cancer patients with or without VTE …
NS Key, N Mackman - Thrombosis Research, 2010 - academia.edu
David A. Manly a, Jianguo Wang a, Sam L. Glover a, Raj Kasthuri a, Howard A. Liebman b, Nigel S. Key a, Nigel Mackman a,⁎ a Division of Hematology/Oncology, Department of …
DA Manly, J Wang, SL Glover, R Kasthuri… - Thrombosis …, 2009 - europepmc.org
Venous thromboembolism (VTE) is the second leading cause of cancer-associated mortality (1). However, cancer patients, particularly in the ambulatory setting, do not routinely receive …
DA Manly, J Wang, SL Glover, R Kasthuri… - Thrombosis …, 2010 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is the second leading cause of cancer-associated mortality (1). However, cancer patients, particularly in the ambulatory setting, do not routinely receive …
DA Manly, J Wang, SL Glover, R Kasthuri… - Thrombosis …, 2010 - infona.pl
Cancer patients exhibit a high rate of thromboembolism (VTE). In this study, we analyzed levels of microparticle (MP) tissue factor (TF) activity in cancer patients with or without VTE …
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
DA Manly, J Wang, SL Glover, R Kasthuri… - Thrombosis …, 2010 - cdr.lib.unc.edu
AbstractCancer patients exhibit a high rate of thromboembolism (VTE). In this study, we analyzed levels of microparticle (MP) tissue factor (TF) activity in cancer patients with or …